Resgen processes non-recyclable plastic and rubber waste into industrial fuels and chemical by-products like carbon black and steel scrap. It generates revenue by selling these green alternatives to energy-intensive industries and trading environmental compliance credits.
The company claims a moat through its 'PyroFlow' catalytic technology, but the financials show high net margins (20%) that are not yet supported by high or stable returns on capital (ROCE 9.9%). The business model relies heavily on regulatory mandates like EPR rather than a distinct cost or brand advantage.
Management has prioritized capacity expansion and land acquisition using IPO proceeds, but the high revenue growth has not translated into EPS growth. Significant funds are being directed toward 'advances for shares' and 'capital advances' rather than direct shareholder returns.
The business collapsed as the gap between accounting profits and actual cash flow became an unbridgeable chasm. While revenue appeared to surge, the capital was trapped in ballooning trade receivables and opaque 'advances for shares' that never yielded productive assets. The revolving door of financial leadership eventually signaled a loss of internal control, and the lack of a genuine competitive advantage meant that once regulatory subsidies for plastic waste shifted, the company's mediocre returns on capital plummeted, leaving shareholders with a capital-intensive shell that could not self-fund its own operations.
RichFakir rates Resgen Ltd's business quality as mediocre — 45/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Resgen Ltd is trading about 18% below our estimate of fair value; we rate its price fair. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Resgen Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Resgen Ltd's fair value is about ₹56 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →